Clinical Trial Update: Efficacy and Safety of Azilsartan Medoxomil Plus Chlorthalidone in Participants With Moderate to Severe Hypertension [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of the combination of azilsartan medoxomil and chlorthalidone in adults with moderate to severe essential hyper…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Hypertension

Drugs mentioned

• Chlorthalidone (chlorthalidone)
• Edarbi (azilsartan medoxomil)

Snippet

Sponsor: Takeda | Conditions: Essential Hypertension | Phase 3 | Status: COMPLETED | Results posted: 2012-03-13